HKSE - Delayed Quote HKD

Pak Fah Yeow International Limited (0239.HK)

2.040 +0.010 (+0.49%)
At close: April 22 at 3:15 PM GMT+8
Loading Chart for 0239.HK
DELL
  • Previous Close 2.030
  • Open 2.080
  • Bid 2.040 x --
  • Ask 2.080 x --
  • Day's Range 2.030 - 2.080
  • 52 Week Range 1.240 - 2.200
  • Volume 56,000
  • Avg. Volume 54,895
  • Market Cap (intraday) 635.746M
  • Beta (5Y Monthly) 0.19
  • PE Ratio (TTM) 6.00
  • EPS (TTM) 0.340
  • Earnings Date Mar 26, 2024
  • Forward Dividend & Yield 0.07 (3.35%)
  • Ex-Dividend Date Jul 8, 2024
  • 1y Target Est --

Pak Fah Yeow International Limited, an investment holding, manufactures, markets, and distributes healthcare products under the Hoe Hin brand name in the People's Republic of China, Hong Kong, Macau, Southeast Asia, North America, the United Kingdom, and internationally. It operates through three segments: Healthcare, Property Investments, and Treasury Investments. The company offers white flower embrocation medicated oils, strain relief products, and ointments under, as well as Fúzai 239, a floral-scented white flower embrocation. In addition, it invests in commercial, industrial, residential, and car park properties; and provides advertising agency services. Pak Fah Yeow International Limited was founded in 1927 and is headquartered in Wan Chai, Hong Kong.

www.pakfahyeow.com

102

Full Time Employees

December 31

Fiscal Year Ends

Related News

Performance Overview: 0239.HK

Trailing total returns as of 4/23/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

0239.HK
15.25%
HANG SENG INDEX
1.28%

1-Year Return

0239.HK
47.95%
HANG SENG INDEX
16.17%

3-Year Return

0239.HK
26.31%
HANG SENG INDEX
41.48%

5-Year Return

0239.HK
17.92%
HANG SENG INDEX
43.83%

Compare To: 0239.HK

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 0239.HK

Valuation Measures

Annual
As of 4/23/2024
  • Market Cap

    632.63M

  • Enterprise Value

    359.76M

  • Trailing P/E

    6.02

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    2.44

  • Price/Book (mrq)

    0.83

  • Enterprise Value/Revenue

    1.39

  • Enterprise Value/EBITDA

    2.63

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    40.47%

  • Return on Assets (ttm)

    10.36%

  • Return on Equity (ttm)

    14.27%

  • Revenue (ttm)

    259.56M

  • Net Income Avi to Common (ttm)

    105.04M

  • Diluted EPS (ttm)

    0.340

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    282.08M

  • Total Debt/Equity (mrq)

    0.62%

  • Levered Free Cash Flow (ttm)

    112.9M

Company Insights: 0239.HK

People Also Watch